Page last updated: 2024-08-25

rosiglitazone and Acute Liver Injury, Drug-Induced

rosiglitazone has been researched along with Acute Liver Injury, Drug-Induced in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (50.00)	29.6817
2010's	20 (41.67)	24.3611
2020's	4 (8.33)	2.80

Authors

Authors	Studies
Goto, A; Nakajima, M; Nezu, J; Nozawa, T; Sugiura, S; Tamai, I; Tsuji, A; Yokoi, T	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S	1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Norman, BH	1
Cao, Y; He, W; Huang, J; Li, X; Wang, J	1
Chen, Y; Feng, L; Huang, C; Jin, L; Li, Y; Li, YM; Lu, S; Song, K; Xue, H; Zhang, J; Zhao, Y; Zheng, Z	1
Bandhakavi, S; Chen, M; Dirven, H; Fitch, SE; Kincaid, B; Leenaars, CHC; Mehta, J; Pound, P; Ram, R; Tsaioun, K; Vist, GE; Wright, RA	1
Khetani, SR; McVay, M; Sunada, WY; Ware, BR	1
Bennett, RG; Hamel, FG; Simpson, RL	1
Chen, SZ; Li, JJ; Li, YY; Yu, FX; Zheng, YH; Zhi, SC	1
Cha, BS; Huh, JH; Kang, ES; Kang, SB; Kim, HJ; Kim, HM; Lee, BW; Lee, HC; Seok, H	1
Chen, H; Chen, W; Jin, Y; Lin, YJ; Zhou, XY	1
Bu, Y; Yu, J	1
Chen, X; Chen, YH; Fu, L; Lu, Y; Wang, BW; Wang, JX; Xu, DX; Zhang, C; Zhang, DG; Zhang, ZH	1
Barbehenn, E; Floyd, JS; Lurie, P; Wolfe, SM	1
Cobitz, AR; Kolatkar, NS; Koro, CE; Osei, SY; Stender, M	1
Beiderbeck, AB; Sakaguchi, M	1
El-Agamy, DS; Said, SA	1
Berthet, S; Lapeyre-Mestre, M; Montastruc, JL; Olivier, P	1
Azar, R; Banner, B; Bird, S; Bonkovsky, HL; Szabo, G	1
Herrmann, A; Hesselbarth, N; Hippius, M; Hoffmann, A; Kuschel, U	1
Fackett, A; Hayden, MJ; Hewitt, NJ; Li, AP; Lloyd, S; Sakai, Y; Silber, PM	1
Kaplowitz, N; Lewis, JH; Watkins, PB	1
Chandramouli, J; Tolman, KG	1
Iyer, S; Perez, A; Rajagopalan, R	1
Freston, JW; Schlichting, CL; Slavin, DE	1
Al-Salman, J; Arjomand, H; Kemp, DG; Mittal, M	1
Kuzuya, T	1
Bailey, CJ; Krentz, AJ; Melander, A	1
Nori, U; Ravinuthala, RS	1
Force, RW; Hachey, DM; O'Neil, MP	1
Funk, WB; Lenhard, MJ	1
Porterfield, LM	1
Gale, EA	1
McMorran, M; Vu, D	1
Cohen, RI; Gouda, HE; Khan, A; Schwartz, J	1
Scheen, AJ	1

Reviews

7 review(s) available for rosiglitazone and Acute Liver Injury, Drug-Induced

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies. Journal of medicinal chemistry, 2020, 10-22, Volume: 63, Issue:20 Topics: Animals; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Drug Discovery; Drug Evaluation, Preclinical; Hepatocytes; Humans; Liver; Mitochondria, Liver; Pharmaceutical Preparations; Risk Assessment; Tissue Distribution	2020
Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review. Scientific reports, 2021, 03-18, Volume: 11, Issue:1 Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Liver; Rosiglitazone; Troglitazone	2021
Hepatotoxicity of the thiazolidinediones. Clinics in liver disease, 2003, Volume: 7, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Liver Failure, Acute; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2003
[The development of thiazolidinedione drugs as anti-diabetic agents]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:2 Topics: Animals; Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Mice; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	2000
Lessons from the glitazones: a story of drug development. Lancet (London, England), 2001, Jun-09, Volume: 357, Issue:9271 Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Approval; Drug Therapy, Combination; Europe; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States	2001
Hepatotoxicity with thiazolidinediones: is it a class effect? Drug safety, 2001, Volume: 24, Issue:12 Topics: Aged; Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Troglitazone	2001

Other Studies

41 other study(ies) available for rosiglitazone and Acute Liver Injury, Drug-Induced

Article	Year
Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:3 Topics: Biological Transport, Active; Chemical and Drug Induced Liver Injury; Chromans; Cloning, Molecular; DNA, Complementary; Estrone; Hepatocytes; Humans; Hypoglycemic Agents; Molecular Sequence Data; Oocytes; Organic Anion Transporters; Pioglitazone; Protein Binding; Quinones; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Troglitazone	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors	2012
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology, 2011, Volume: 7, Issue:12 Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:3 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index	2014
Rosiglitazone Protects against Acetaminophen-Induced Acute Liver Injury by Inhibiting Multiple Endoplasmic Reticulum Stress Pathways. BioMed research international, 2022, Volume: 2022 Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Liver; Male; Mice; Necrosis; Oxidative Stress; Rosiglitazone	2022
Identification of an allosteric hotspot for additive activation of PPARγ in antidiabetic effects. Science bulletin, 2021, 08-15, Volume: 66, Issue:15 Topics: Animals; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Mice; PPAR gamma; Rosiglitazone; Thiazolidinediones; Weight Gain	2021
Exploring Chronic Drug Effects on Microengineered Human Liver Cultures Using Global Gene Expression Profiling. Toxicological sciences : an official journal of the Society of Toxicology, 2017, 06-01, Volume: 157, Issue:2 Topics: 3T3 Cells; Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chromans; Coculture Techniques; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Profiling; Hepatocytes; Humans; Liver; Mice; Oxidative Stress; Primary Cell Culture; Rosiglitazone; Thiazolidinediones; Toxicogenetics; Transcriptome; Troglitazone	2017
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis. World journal of gastroenterology, 2017, Jun-14, Volume: 23, Issue:22 Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Collagen Type I; Drug Therapy, Combination; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Recombinant Proteins; Relaxin; Rosiglitazone; Thiazolidinediones	2017
Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis. Digestive diseases and sciences, 2019, Volume: 64, Issue:6 Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen Type I; Collagen Type I, alpha 1 Chain; Hepatic Stellate Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice, Inbred BALB C; MicroRNAs; PPAR gamma; RNA, Long Noncoding; Rosiglitazone; Signal Transduction; Up-Regulation	2019
Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress. Endocrine journal, 2013, Volume: 60, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Body Weight; Caseins; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endoplasmic Reticulum Stress; Inflammation; Liver; Male; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones	2013
Rosiglitazone protects rat liver against acute liver injury associated with the NF-κB signaling pathway. Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:1 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; Disease Models, Animal; Inflammation Mediators; Interleukin-6; Male; NF-kappa B; Protective Agents; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Necrosis Factor-alpha	2016
[Rosiglitazone protects against endotoxin-induced acute liver injury in rats]. Zhonghua yi xue za zhi, 2015, Oct-20, Volume: 95, Issue:39 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cytokines; Endotoxins; Liver; Rats; Rosiglitazone; Sepsis; Thiazolidinediones	2015
Protective effect of rosiglitazone against acetaminophen-induced acute liver injury is associated with down-regulation of hepatic NADPH oxidases. Toxicology letters, 2017, Jan-04, Volume: 265 Topics: Acetaminophen; Animals; Cell Death; Chemical and Drug Induced Liver Injury; Down-Regulation; Glutathione; In Situ Nick-End Labeling; Lipid Peroxidation; Liver; Male; Mice, Inbred Strains; NADPH Oxidases; PPAR gamma; Rosiglitazone; Thiazolidinediones	2017
Case series of liver failure associated with rosiglitazone and pioglitazone. Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Pioglitazone; Risk Factors; Rosiglitazone; Thiazolidinediones; Time Factors	2009
Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al. Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazolidinediones	2009
Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al. Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazolidinediones	2009
Prevention of sodium valproate-induced hepatotoxicity by curcumin, rosiglitazone and N-acetylcysteine in rats. Arzneimittel-Forschung, 2010, Volume: 60, Issue:11 Topics: Acetylcysteine; Animals; Anticonvulsants; Body Weight; Chemical and Drug Induced Liver Injury; Convulsants; Curcumin; Eating; Fatty Liver; Free Radical Scavengers; Hypoglycemic Agents; Liver; Liver Function Tests; Male; Mice; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Rosiglitazone; Seizures; Thiazolidinediones; Valproic Acid	2010
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database. BMC clinical pharmacology, 2011, May-24, Volume: 11 Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Diabetes Mellitus, Type 2; Edema; Female; France; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Pioglitazone; Rosiglitazone; Thiazolidinediones	2011
Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone. Digestive diseases and sciences, 2002, Volume: 47, Issue:7 Topics: Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Cholestasis; Chromans; Female; Humans; Hypoglycemic Agents; Liver Function Tests; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Transaminases; Troglitazone	2002
[Severe electrolyte imbalance and edema in therapy with rosiglitazone]. Medizinische Klinik (Munich, Germany : 1983), 2002, Sep-15, Volume: 97, Issue:9 Topics: Chemical and Drug Induced Liver Injury; Contraindications; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Water-Electrolyte Imbalance	2002
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors. Chemico-biological interactions, 2002, Nov-10, Volume: 142, Issue:1-2 Topics: Adenosine Triphosphate; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Chemical and Drug Induced Liver Injury; Chromans; Coloring Agents; Female; Formazans; Glutathione; Hepatocytes; Humans; Hypoglycemic Agents; Infant; Liver Diseases; Male; Middle Aged; Neutral Red; Oxazines; Rosiglitazone; Sex Factors; Smoking; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Troglitazone; Xanthenes	2002
[Meta-analysis shows: insulin sensitizer is safe for the liver]. MMW Fortschritte der Medizin, 2002, Oct-03, Volume: 144, Issue:40 Topics: Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hypoglycemic Agents; Meta-Analysis as Topic; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	2002
Did this drug cause my patient's hepatitis? Annals of internal medicine, 2003, Jan-21, Volume: 138, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Pioglitazone; Product Surveillance, Postmarketing; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	2003
Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone. Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Liver Failure; Male; Metformin; Middle Aged; Pioglitazone; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones	2005
Rating the severity of the medical consequences of drug-induced liver injury. Regulatory toxicology and pharmacology : RTP, 2005, Volume: 43, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Chromans; Data Collection; Humans; Hypoglycemic Agents; Liver; Liver Function Tests; Pioglitazone; Risk Assessment; Rosiglitazone; Surveys and Questionnaires; Thiazolidinediones; Troglitazone	2005
Hepatocellular injury in a patient receiving rosiglitazone. A case report. Annals of internal medicine, 2000, Jan-18, Volume: 132, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver; Liver Function Tests; Male; Middle Aged; Monitoring, Physiologic; Rosiglitazone; Thiazoles; Thiazolidinediones	2000
Correction: Liver injury and rosiglitazone. Annals of internal medicine, 2000, Aug-01, Volume: 133, Issue:3 Topics: Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Indoles; Phenylcarbamates; Rosiglitazone; Sulfonamides; Thiazoles; Thiazolidinediones; Tosyl Compounds	2000
Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. BMJ (Clinical research ed.), 2000, Jul-29, Volume: 321, Issue:7256 Topics: Chemical and Drug Induced Liver Injury; Chromans; Contraindications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	2000
Rosiglitazone toxicity. Annals of internal medicine, 2000, Oct-17, Volume: 133, Issue:8 Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones	2000
Isolated elevation of alkaline phosphatase level associated with rosiglitazone. Annals of internal medicine, 2000, Nov-07, Volume: 133, Issue:9 Topics: Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Middle Aged; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones	2000
Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis. Diabetes care, 2001, Volume: 24, Issue:1 Topics: Adult; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	2001
What caused this patient's sudden liver dysfunction? RN, 2001, Volume: 64, Issue:3 Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones	2001
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Jul-10, Volume: 165, Issue:1 Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones	2001
Liver failure in a patient treated with long-term rosiglitazone therapy. The American journal of medicine, 2001, Volume: 111, Issue:7 Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Liver Failure; Male; Rosiglitazone; Thiazoles; Thiazolidinediones	2001